Intracranial pressure dynamics

9 min read Last updated April 8, 2026

Clinical framework: assessing and managing raised ICP

  • Define the problem and the target
    • ICP: normal adult supine ~7–15 mmHg (≈10–20 cmH2O). Sustained >20–22 mmHg often treated in TBI pathways.
    • CPP = MAP − ICP (or MAP − CVP if CVP > ICP). Typical target in severe TBI often 60–70 mmHg (local protocol-dependent).
  • Immediate priorities (physiology-first)
    • Airway/ventilation: avoid hypoxia; short-term mild hypocapnia only as a temporising measure if herniation suspected.
    • Perfusion: maintain MAP; avoid hypotension (single episode worsens outcome in TBI).
    • Positioning/venous drainage: head up ~30°, neutral neck, avoid tight ETT ties, minimise PEEP if it impairs venous return.
  • Treat reversible causes of ICP spikes
    • Pain, coughing/straining, agitation, hypercapnia, hypoxia, fever, seizures, obstruction to venous drainage, hyponatraemia/hypo-osmolality.
    • Sedation/analgesia, paralysis if needed, normothermia, seizure control, correct sodium/osmolality, optimise ventilation and venous drainage.
  • Escalation options (context-dependent)
    • CSF drainage (EVD), hyperosmolar therapy (mannitol or hypertonic saline), controlled ventilation, surgical decompression, barbiturate coma (selected), targeted temperature management (selected).
    • Balance ICP reduction against CPP: an intervention that lowers ICP but also lowers MAP may not improve CPP.

Core concepts: volumes, pressures, and compliance

  • Monro–Kellie doctrine: the cranial vault is effectively fixed volume; total intracranial volume = brain (~80%) + blood (~10%) + CSF (~10%).
    • An increase in one component must be compensated by a decrease in another, otherwise ICP rises.
    • Compensation mechanisms: CSF displacement to spinal compartment, increased CSF absorption/reduced production, venous blood displacement (venous capacitance).
  • Compliance (C) and elastance (E): C = ΔV/ΔP; E = ΔP/ΔV. As compensatory reserve is exhausted, small ΔV causes large ΔP (steep pressure–volume curve).
    • Clinical implication: late in the curve, minor events (coughing, suctioning, small haematoma expansion) can precipitate major ICP surges and herniation.
  • Intracranial pressure–volume curve: early flat (good compliance), then exponential rise (poor compliance).
    • ‘Compensatory reserve’ is the remaining ability to buffer added volume without large ICP rise (related to intracranial compliance).

ICP waveform and what it means

  • ICP waveform has pulsatile and slow components.
    • Cardiac-related peaks: P1 (percussion, arterial transmission), P2 (tidal, compliance), P3 (dicrotic).
    • Normal: P1 > P2 > P3. Reduced compliance: P2 rises and can exceed P1 (P2 > P1).
  • Lundberg waves (slow waves):
    • A waves (plateau): abrupt rise to ~50–100 mmHg for 5–20 min, then fall; indicates severely reduced compliance and risk of herniation.
    • B waves: rhythmic 0.5–2/min oscillations; may reflect changes in cerebral blood volume/respiratory pattern; can precede A waves.
    • C waves: smaller, more frequent; often related to systemic BP/vasomotor rhythms; less specific.
  • Mean ICP is most used clinically, but waveform morphology gives information about compliance and impending decompensation.

CPP, cerebral autoregulation, and pressure reactivity

  • CPP = MAP − ICP (or MAP − CVP if CVP higher).
    • If ICP rises, CPP falls unless MAP increases; if MAP falls, CPP falls even if ICP unchanged.
  • Autoregulation: cerebral arterioles adjust resistance to maintain CBF across a CPP range (classically ~50–150 mmHg in healthy adults).
    • Shifted right in chronic hypertension (higher lower limit).
    • Impaired in TBI, SAH, tumours, severe hypoxia/ischaemia, sepsis, anaesthetic effects; then CBF becomes pressure-passive.
  • Pressure reactivity: ability of cerebral vessels to constrict when MAP rises (reducing CBV and limiting ICP rise).
    • If pressure reactivity is lost, increases in MAP can increase CBV and raise ICP (worsening CPP).

Determinants of ICP: cerebral blood volume, CSF dynamics, and brain water

  • Cerebral blood volume (CBV): influenced by arterial/venous tone and venous outflow.
    • PaCO2: potent modulator. Hypercapnia → vasodilation → ↑CBF/CBV → ↑ICP. Hypocapnia → vasoconstriction → ↓CBF/CBV → ↓ICP (but risks ischaemia).
    • PaO2: little effect until PaO2 < ~50 mmHg (6.7 kPa) → vasodilation → ↑CBF/CBV → ↑ICP.
    • Venous factors: raised intrathoracic pressure, high PEEP, coughing/straining, neck flexion/rotation, jugular obstruction → impaired venous drainage → ↑CBV → ↑ICP.
  • CSF dynamics: production mainly by choroid plexus (~0.3–0.4 mL/min; ~500 mL/day). Total CSF volume ~150 mL; turnover ~3–4×/day.
    • Absorption via arachnoid granulations into dural venous sinuses; depends on pressure gradient between CSF and venous sinus pressure.
    • Obstructive hydrocephalus increases CSF volume and ICP; EVD can reduce ICP and improve compliance.
  • Brain water (oedema): cytotoxic (cellular swelling), vasogenic (BBB disruption), interstitial (hydrocephalus-related), osmotic.
    • Hyperosmolar therapy reduces brain water by creating an osmotic gradient (requires intact BBB for maximal effect; still useful in raised ICP).

Physiological manoeuvres and anaesthetic drugs: expected effects on ICP/CBF/CMRO2

  • Ventilation: aim normocapnia in most; brief mild hypocapnia (e.g., PaCO2 ~4.0–4.5 kPa) as temporising measure in acute herniation while definitive therapy arranged.
    • Prolonged aggressive hyperventilation can cause cerebral ischaemia (reduced CBF) and worsen outcome in TBI.
  • IV induction agents: propofol/thiopentone reduce CMRO2 and CBF (coupled), generally lower ICP (if MAP maintained).
    • Ketamine: historically avoided; contemporary evidence suggests it does not necessarily raise ICP when ventilation controlled and sedation provided; can support MAP/CPP. Still consider context and local practice.
  • Volatile agents: dose-dependent cerebral vasodilation → ↑CBF/CBV and can ↑ICP; also reduce CMRO2. Net effect depends on dose, PaCO2, and autoregulation status.
    • At low MAC with controlled PaCO2, acceptable in many neurosurgical cases; high MAC or hypercapnia increases ICP risk.
  • Opioids: minimal direct effect on CBF/ICP; but hypoventilation → hypercapnia → ↑ICP. Large boluses may reduce MAP → ↓CPP.
  • Neuromuscular blockade: prevents coughing/straining and facilitates ventilation → helps control ICP.
  • PEEP: may raise ICP by increasing intrathoracic pressure and reducing cerebral venous drainage; effect is variable and depends on lung compliance, CVP, and volume status.
    • If PEEP improves oxygenation and reduces PaCO2 needs, net effect may be beneficial; monitor CPP/ICP where possible.

Herniation syndromes (linking ICP dynamics to clinical signs)

  • Raised ICP reduces CPP → global ischaemia; focal mass effect causes shifts and herniation.
  • Cushing response: hypertension + bradycardia + irregular respiration (late sign of raised ICP/brainstem compression).
  • Uncal (transtentorial) herniation: ipsilateral 3rd nerve palsy (dilated pupil), contralateral weakness; may progress to brainstem signs.
  • Tonsillar herniation: brainstem compression → cardiorespiratory instability; can be precipitated by CSF drainage in presence of mass lesion.
Explain the Monro–Kellie doctrine and its clinical relevance to raised ICP.

A common FRCA viva theme: fixed cranial volume, compensation, then decompensation.

  • Total intracranial volume is fixed: brain + blood + CSF. Increase in one must be offset by decrease in another or ICP rises.
  • Early compensation: CSF displaced to spinal compartment; venous blood displaced; altered CSF absorption/production.
  • Once compensatory reserve exhausted, compliance falls and ICP rises steeply with small volume increases (risk of sudden deterioration).
Describe the intracranial pressure–volume curve and define compliance and elastance.

Often asked to link the curve to clinical events (coughing, suctioning, haematoma expansion).

  • Compliance C = ΔV/ΔP; elastance E = ΔP/ΔV.
  • Early curve: high compliance (flat) due to CSF/venous displacement. Late curve: low compliance (steep/exponential) with large ICP rises for small ΔV.
  • Clinical implication: late on curve, minor stimuli (coughing, positioning, hypercapnia) can cause large ICP spikes and herniation.
What is cerebral perfusion pressure (CPP)? How do you calculate it and what are the limitations?

FRCA commonly tests the nuance of CVP and the difference between pressure and flow.

  • CPP = MAP − ICP; if CVP exceeds ICP, the effective downstream pressure is CVP, so CPP ≈ MAP − CVP.
  • CPP is a pressure surrogate, not direct CBF; if autoregulation impaired, CBF becomes pressure-passive and CPP targets may not ensure adequate flow.
  • Raising MAP may increase CPP but can worsen ICP if pressure reactivity is impaired (increased CBV).
Describe the ICP waveform (P1, P2, P3). What does an increased P2 signify?

A classic viva: waveform interpretation as a marker of compliance.

  • P1 (percussion) reflects arterial pulsation transmission; P2 (tidal) reflects intracranial compliance; P3 relates to dicrotic wave.
  • Normal: P1 > P2 > P3. Raised P2 (P2 > P1) indicates reduced intracranial compliance (poor compensatory reserve).
What are Lundberg A, B and C waves? Which is most concerning and why?

Frequently examined as part of ICP monitoring interpretation.

  • A waves (plateau): large sustained rises (often 50–100 mmHg for 5–20 min) indicating critically reduced compliance and high herniation risk.
  • B waves: moderate rhythmic oscillations (0.5–2/min), may indicate evolving intracranial pathology and reduced reserve.
  • C waves: small frequent oscillations, often related to systemic vasomotor rhythms; less specific.
Explain how PaCO2 affects ICP and why hyperventilation is a temporising measure rather than definitive therapy.

FRCA often expects numbers/thresholds and risks.

  • CO2 diffuses rapidly into CSF; ↑PaCO2 → ↓CSF pH → cerebral vasodilation → ↑CBF/CBV → ↑ICP. ↓PaCO2 does the opposite.
  • Hyperventilation reduces ICP quickly but also reduces CBF and can precipitate cerebral ischaemia, especially in injured brain with impaired autoregulation.
  • CO2 effect can attenuate over hours due to CSF bicarbonate buffering; hence not a durable solution.
How does hypoxia affect CBF and ICP? At what PaO2 does CBF start to rise significantly?

Often paired with CO2 physiology.

  • PaO2 has little effect on CBF until significant hypoxaemia; below ~50 mmHg (6.7 kPa), cerebral vasodilation increases CBF/CBV and can increase ICP.
  • Hypoxia also worsens cerebral metabolic stress and can impair autoregulation, compounding ICP/CPP problems.
A ventilated head-injured patient has ICP 28 mmHg and MAP 70 mmHg. Calculate CPP and outline immediate management priorities.

This mirrors common FRCA structured viva calculations and prioritisation.

  • CPP = 70 − 28 = 42 mmHg (low).
  • Immediate: ensure oxygenation, normocapnia (brief mild hypocapnia if herniation), optimise venous drainage (head up/neutral neck), deepen sedation/analgesia ± paralysis, treat fever/seizures.
  • Support MAP with fluids/vasopressors to restore CPP while treating ICP (e.g., hyperosmolar therapy, CSF drainage if EVD, urgent imaging/surgery as indicated).
Discuss how PEEP and intrathoracic pressure can influence ICP and CPP.

A common anaesthetic physiology viva: venous drainage and downstream pressure.

  • Increased intrathoracic pressure can raise CVP and impede cerebral venous drainage → ↑CBV → ↑ICP; if CVP exceeds ICP, CPP becomes MAP − CVP.
  • Effect is variable: if PEEP improves oxygenation and reduces hypoxic vasodilation, net ICP may improve; depends on lung compliance, volume status, and head position.
  • Practical: use the lowest PEEP compatible with oxygenation; monitor CPP/ICP where possible; avoid excessive hypercapnia.
Compare the expected effects of propofol, thiopentone, volatile agents and ketamine on ICP.

Drug effects on CBF/CMRO2/CBV are recurring FRCA questions.

  • Propofol/thiopentone: ↓CMRO2 and ↓CBF (coupled) → usually ↓ICP; beware hypotension reducing CPP.
  • Volatiles: dose-dependent vasodilation → ↑CBF/CBV and may ↑ICP; also ↓CMRO2. Control PaCO2 and avoid high MAC if ICP a concern.
  • Ketamine: may preserve/increase MAP and thus CPP; when ventilation controlled and co-sedation used, evidence does not show consistent ICP rise; still consider individual pathology and local guidance.
Explain why coughing, straining, and suctioning can cause dangerous ICP surges, especially in patients with poor intracranial compliance.

Links physiology (venous pressure, CBV) to bedside events.

  • Coughing/straining increases intrathoracic pressure and CVP → impairs cerebral venous drainage → ↑CBV → ↑ICP.
  • In low compliance (steep P–V curve), small CBV increases cause large ICP rises; can precipitate herniation and reduce CPP abruptly.
  • Mitigation: adequate analgesia/sedation, lidocaine/short-acting opioid for stimulation, paralysis if needed, gentle suctioning, ensure tube tolerance.

0 comments